FDA to Approve New Covid Vaccine with Single Shot
Travel demand has been picking up in recent weeks. TSA also signaled that it expects to see a big boost during the summer, as it is looking to hire 6,000 new agents.
One of the reasons for increased travel demand has been the rollout of two vaccines by Pfizer and Moderna. Now a third option is expected to be approved in the coming days by the Food and Drug Administration (FDA).
The FDA’s staff endorsed Johnson & Johnson’s Covid-19 vaccine for emergency use. That is a critical step for the vaccine to become available for Americans. The staff report is meant to brief the FDA’s Vaccines and Related Biological Products Advisory Committee, which will meet Friday to review J&J’s request for emergency use. The FDA doesn’t have to follow the committee’s recommendation, but it often does, CNBC reports.
J&J vaccine is different from the two other options currently in the market as it only requires one dose. That makes it easier logistically for health-care providers to administer it. J&J is seeking authorization to use the vaccine in people age 18 and older. The company has a deal with the federal government to supply 100 million doses of its vaccine by the end of June.